Related by context. All words. (Click for frequent words.) 76 humanized anti 75 Epratuzumab 74 oral prodrug 73 investigational humanized monoclonal antibody 72 HuLuc# 72 IAP inhibitor 72 erlotinib Tarceva ® 72 Milatuzumab 72 proteasome inhibitor 71 mertansine 71 receptor tyrosine kinase inhibitor 71 ENMD # 71 CD# antibody [001] 71 Factor VIIa 71 Dapagliflozin 71 cancer vaccine Norelin 71 cilengitide 71 Daclizumab 70 AEG# 70 pan HDAC inhibitor 70 MT#/MEDI-# 70 bevacizumab Avastin ® 70 PKC# 70 humanized monoclonal 70 Traficet EN 70 XmAb# 70 humanized antibody 70 liposomal formulation 70 CD4 monoclonal antibody 70 familial amyloidotic polyneuropathy FAP 70 oral antiviral 70 CD3 monoclonal antibody 70 humanized monoclonal antibody 70 tyrosine kinase inhibitor 70 monoclonal antibody mAb 70 Epidermal Growth Factor Receptor 70 Nanobody ® 70 protein kinase inhibitor 69 Azedra 69 #D#C# 69 selective inhibition 69 sunitinib Sutent ® 69 EGFR HER2 69 alpha#beta# integrin 69 JAK inhibitor 69 Xanafide 69 selective antagonist 69 effector function 69 dasatinib Sprycel ® 69 CYT# potent vascular disrupting 69 MKC# MKC# PP 69 CBLC# 69 Carfilzomib 69 Anidulafungin 69 FLT3 69 MAGE A3 ASCI 69 Symadex 69 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 69 Bortezomib 69 sodium glucose cotransporter 69 immunomodulator 69 RAF kinase 69 investigational monoclonal antibody 69 HepDirect prodrug 69 Protein Kinase C 69 Panzem R 69 IAP inhibitors 68 Vidofludimus 68 Sapacitabine 68 BAL# [001] 68 PKC isoforms 68 PDE4 inhibitor 68 ADP receptor antagonist 68 BAY #-# 68 HQK 68 Proxinium TM 68 histone deacetylase inhibitor 68 Nanobody 68 Dasatinib 68 androgen receptor AR 68 Sym# 68 phase IIb clinical 68 IMA# 68 interleukin IL -# 68 GW# [003] 68 CCX# 68 HuMax HepC TM 68 PEG SN# 68 Omacetaxine 68 CYC# 68 Methylnaltrexone 68 myelofibrosis polycythemia vera 68 humanized antibodies 68 NS#/#A protease 68 targeting CD# 68 T#M mutation 68 targeted radiotherapeutic 68 YONDELIS 68 cancer immunotherapies 68 Aplidin R 68 CDK inhibitor 68 monoclonal antibody MAb 68 oncolytic 68 mapatumumab 68 cetuximab Erbitux R 68 REP# 68 orally administered inhibitor 68 Degarelix 68 histone deacetylase HDAC 68 CD# CEA 68 SGLT2 68 Annamycin 68 nicotinic alpha 7 68 HDACi 68 Chemokine Receptor 68 Pazopanib 68 RECOTHROM R 68 Vorinostat 68 VEGF receptor 68 nucleoside analog 68 Factor VEGF 68 Teriflunomide 68 polymerase inhibitors 68 antibody fragment 68 HCV polymerase 68 HuMax CD4 68 HGS# 68 Ridaforolimus 68 PI3K inhibitor 68 HSP# inhibitor 68 Enzastaurin 68 multi kinase inhibitor 68 drug conjugate 68 kidney urologic 68 bispecific 67 potent cytotoxic 67 chimeric monoclonal antibody 67 vapreotide acetate 67 HGS ETR1 mapatumumab 67 Aurora kinase 67 FOLOTYN ® 67 fosbretabulin 67 anti CD# monoclonal 67 PSMA ADC 67 Cytochrome P# 67 GTC recombinant human 67 protein tyrosine phosphatase 1B 67 bevacizumab Avastin R 67 solithromycin 67 polymerase inhibitor 67 IgG1 67 SCH # 67 Aliskiren 67 Irinotecan 67 DNA intercalator 67 pathophysiological effects 67 FK# 67 ATL/TV# 67 HCD# [002] 67 anticancer agent 67 cytotoxin 67 NS5b 67 cathepsin K inhibitor 67 NXL# 67 huC# DM4 67 alpha folate receptor 67 imatinib Gleevec ® 67 diarrhea predominant irritable 67 Exherin TM 67 Cloretazine 67 PDX pralatrexate 67 PEGylated 67 docetaxel Taxotere R 67 MEK inhibitor 67 ALN TTR 67 virus HCV protease inhibitor 67 Amplimexon 67 OXi# 67 PRTX 67 vinca alkaloid 67 metastatic neuroendocrine tumors 67 amikacin 67 Novel Oral 67 volociximab 67 Gleevec resistant 67 depsipeptide 67 MKC# MT 67 reslizumab 67 POTELLIGENT ® 67 AKT inhibitor 67 C5aR 67 CORT # 67 mu opioid receptor antagonist 67 hypoxia inducible factor 67 dSLIM 67 Ceflatonin R 67 Phase Ib clinical trials 67 poly ADP ribose polymerase 67 somatostatin analogue 67 ATL# [001] 67 adenoviral 67 TG# [003] 67 beta 1a 67 Ocrelizumab 67 Ganciclovir 67 immunostimulatory 67 velafermin 67 Resten NG 67 NS4A 67 sphingosine kinase 67 XL# anticancer compounds 67 MYDICAR ® 67 oral kinase inhibitor 67 immune modulatory 67 anti CD3 antibody 67 nucleoside analogues 67 HGS ETR2 67 tiapamil 67 Safinamide 67 AQ4N 67 Tyrima 66 ABLYNX 66 Locked Nucleic Acid LNA 66 monoclonal 66 Blinatumomab 66 metaglidasen 66 PEGylated Fab fragment 66 thalidomide Thalomid 66 TELINTRA 66 Fibroblast Growth Factor Receptor 66 BAL# [002] 66 peripherally acting 66 poly ethylene glycol PEG 66 selective modulator 66 Rilonacept 66 synthetic retinoid 66 modulator SERM 66 IL #E 66 T#I [002] 66 BCR ABL inhibitors 66 imatinib Gleevec 66 lymphotoxin 66 murine monoclonal antibody 66 antisense oligonucleotide 66 taxane derivative 66 JAK2 enzyme 66 mTOR mammalian target 66 targeted antifolate 66 VEGF inhibitors 66 IgG1 antibody 66 pharmacokinetic interactions 66 Fc fusion protein 66 TRISENOX ® 66 Epothilones 66 RhuDex ® 66 A3 adenosine receptor 66 small molecule thrombopoietin 66 Liposomal 66 oncolytic virus therapies 66 novel antibody therapeutics 66 MTP inhibitor 66 cytostatic 66 vivo validation 66 lumiliximab 66 PTP 1B 66 BXT # 66 selective adenosine 66 MEK inhibitors 66 non nucleoside inhibitor 66 Myocet 66 Granulocyte Colony Stimulating Factor 66 ON #.Na 66 HuMax EGFr 66 elotuzumab 66 Aurora kinase inhibitor 66 gefitinib Iressa 66 riociguat 66 Elotuzumab 66 Golimumab 66 Dalbavancin 66 proteasome inhibitors 66 docetaxel Taxotere ® 66 Deforolimus 66 TRANSDUR ™ 66 VAPRISOL 66 Fludara ® 66 JAK1 66 Phase 2a Clinical Trial 66 coronary vasodilation 66 AAG geldanamycin analog 66 GRNVAC1 66 Apaziquone 66 rhMBL 66 histone deacetylase HDAC inhibitor 66 phase Ib clinical 66 selective orally bioavailable 66 huN# DM1 66 MT# MEDI 66 arsenic trioxide injection 66 JAK3 66 Guanilib 66 IMiDs ® compound 66 rilonacept 66 JAK inhibitors 66 antitumoral 66 Triolex 66 anticancer therapies 66 novel VDA molecule 66 Aplidin 66 echinocandin 66 leukotriene pathway 66 Pertuzumab 66 antisense inhibitor 66 FGFR 66 Anti Tumor 66 selective immunoproteasome inhibitor 66 LymphoStat B belimumab 66 inhibitor RG# 66 Kinase Inhibitor 66 5 HT2A inverse 66 anti amnesic 66 Otelixizumab 66 Maribavir 66 Romidepsin 66 Onalta 66 antibody MAb 66 inhaled formulation 66 Nexavar ® 66 Vascular Endothelial Growth 66 TACI Ig 66 IMiDs 66 TNFa 66 Litx 66 apoptosis proteins 66 Kahalalide F 66 MGd 66 replicon 66 syngeneic 66 Ofatumumab 66 mediated apoptosis 66 ALN HPN 66 DUROS 66 histamine dihydrochloride 66 Alfacell proprietary ribonuclease 66 anti angiogenic agent 66 adenosine A2A 66 Trastuzumab 66 SAR# [002] 66 TRX1 66 IMiD 66 novel peptide 66 Atripla combines 66 tubulin binding 66 stable nucleic acid 66 Navelbine ® 66 bicalutamide 66 QUADRAMET R 66 IMiDs R 66 direct thrombin inhibitors 66 TNF Tumor Necrosis Factor 66 5 HT6 66 muscarinic 66 DXL# 66 M1 muscarinic 66 Enkephalin 66 KL4 Surfactant 66 oral proteasome inhibitor 66 mesylate 66 B lymphocyte stimulator 66 BMS # 65 Hsp# Inhibitor 65 TAFA# 65 Bicifadine 65 telaprevir VX 65 daptomycin 65 NTDDS 65 HCV protease 65 Zorbtive TM 65 enzyme inhibitor 65 hormone LHRH antagonist 65 anti CD3 65 acetonide FA 65 L asparaginase 65 Shigamabs ® 65 PRT# 65 glucagon receptor 65 IFN g 65 STEDESA 65 Panzem 65 Bezielle 65 nucleotide analog 65 immunomodulatory 65 antisense inhibitors 65 Annexin V 65 SGLT2 inhibitors 65 Alocrest 65 highly selective endothelin 65 allogeneic cell 65 dasatinib Sprycel 65 Immunotherapeutic 65 flavopiridol 65 trastuzumab Herceptin R 65 opioid receptor antagonist 65 nilotinib Tasigna 65 intravesical instillation 65 TLR9 agonist 65 thymalfasin 65 CEQ# 65 Lenocta 65 vorinostat 65 mTOR inhibitor 65 ZFP TF 65 Ceflatonin 65 idarubicin 65 VEGFR2 65 Phase Ib II 65 Mg Usa 65 CCR9 antagonist 65 CIMZIA ™ 65 EndoTAG TM -1 65 Aflibercept 65 tiuxetan 65 Afatinib 65 SERMs 65 trastuzumab Herceptin 65 Epstein Barr Virus EBV 65 refractory chronic lymphocytic 65 soluble tumor necrosis 65 alvespimycin 65 Pancreate 65 VitiGam 65 Preclinical studies suggest 65 peroxidase 65 XL# XL# XL# 65 Bucindolol 65 5 HT6 receptor 65 Eculizumab 65 Onalta TM 65 atacicept 65 rhIL 7 65 cyclin dependent kinases 65 orally bioavailable 65 sorafenib tablets 65 Tesetaxel 65 5alpha reductase 65 CR# vcMMAE 65 vidofludimus 65 oral Janus kinase 65 Panzem R NCD 65 subcutaneous formulation 65 ALN TTR# 65 investigational protease inhibitor 65 Tumor Necrosis Factor 65 multikinase inhibitor 65 deCODE chemistry 65 chemically modified siRNA 65 T#I mutant 65 neuraminidase inhibitor 65 Liprotamase 65 TMC# C# 65 selective inhibitors 65 relapsing multiple sclerosis 65 sPLA2 65 cytoprotective 65 highly selective inhibitor 65 AVE# 65 Chemophase 65 Archexin 65 inhibit oxidative stress 65 M2 subunit 65 epigenetic therapies 65 Revimmune 65 gonadotropin releasing hormone GnRH 65 selective kinase inhibitor 65 OncoVex 65 Elvitegravir 65 humanized monoclonal antibodies 65 Silodosin 65 RON Notch 65 Azacitidine 65 potent antiproliferative 65 intravesical infusion therapy 65 zanolimumab 65 ErbB3 65 angiotensin receptor blocker ARB 65 PXD# 65 Fas ligand 65 EGFr 65 ganetespib 65 chemotherapeutic drug 65 Mipomersen 65 R Saizen R 65 Alfimeprase 65 Mitoxantrone 65 small molecule chemotherapeutic 65 hormone agonist 65 chemokine receptor 65 S/GSK# 65 dacetuzumab 65 antifungal agent 65 Interferon Beta 65 PSN# [002] 65 Rituximab 65 evaluating tivozanib 65 lapatinib Tykerb 65 Plasmin 65 Monoclonal Antibody 65 radiolabeled monoclonal antibody 65 immunomodulation 65 Neulasta ® 65 EGFR TKIs 65 polyclonal antibody 65 Human cl 65 Luteinizing Hormone Releasing Hormone 65 brand ciclesonide HFA 65 phase IIb trial 65 Lubiprostone 65 pertuzumab 65 Tarceva TM 65 TLK# 65 PNP inhibitor 65 small molecule Hedgehog 65 lucinactant 65 PDE4 65 vascular disrupting 65 triphendiol 65 drug pipeline TAFA# 65 oncolytic virus 65 IgG1 monoclonal antibody 65 therapeutic monoclonal antibody 65 favorable pharmacokinetic profile 65 HCV protease inhibitor 65 JAK2 inhibitor 65 immunomodulating 65 milatuzumab 65 MAbs targeting 65 Meets Primary Endpoint 65 immune stimulatory 65 CYP3A 65 non nucleoside 65 Bevacizumab 65 Tezampanel 65 angiogenesis inhibitor 65 antibody MT# 65 gastrin 65 octreotide acetate 65 novel immunomodulatory 65 adalimumab Humira 65 Personalized Immunotherapy 65 Imprime PGG 65 Davunetide 65 nucleoside analogs 65 XL# XL# 65 Tarvacin TM 65 Anticalin R 65 anti CD# antibodies 65 Cethromycin 65 Platelet Derived Growth 65 reversible inhibitors 65 cell mediated cytotoxicity 65 antifibrotic 65 azacytidine 65 tumor xenograft models 65 multicenter Phase III 65 cyclophilin inhibitor 65 c MET 65 goserelin 65 agonistic human 65 ritonavir boosted 65 PEGylated interferon 65 R lenalidomide 65 p# mitogen activated 65 Angiolix 65 immunomodulatory therapy 65 plasma kallikrein inhibitor 65 receptor inhibitor 64 TO AVOID PREGNANCY WHILE 64 Octreotide 64 Recombinant Human 64 TKB# 64 either acutely decompensated 64 experimental autoimmune encephalomyelitis 64 rituximab Rituxan 64 Bruton tyrosine kinase 64 ERK1 2 64 Onconase 64 Glufosfamide 64 castrate resistant prostate cancer 64 visilizumab 64 orally bioavailable mimics 64 selective androgen receptor modulator 64 hepatoma 64 interferon IFN 64 ceftazidime 64 CA4P 64 ara C 64 Curaxin CBLC# 64 MMAE 64 LHRH antagonists 64 multicenter Phase II 64 Tiuxetan 64 deacetylation 64 mGlu2 3 64 Pharmacokinetics PK 64 Cloretazine ® 64 erlotinib Tarceva R 64 GPIIb IIIa 64 Zolinza 64 Alinia 64 cortisol receptor 64 SinuNase ™ 64 Squalamine 64 alkylating agent 64 receptor modulators 64 R bendamustine hydrochloride 64 PD LID 64 CDP# 64 Aurora Kinase 64 Anticalin ® 64 gamma secretase inhibitors 64 LymphoStat B TM 64 Cethrin R 64 HuMax CD# 64 cMET 64 5 HT4 64 Exelixis XL# 64 MCSP respectively 64 receptor partial agonist 64 Genentech Rituxan 64 small molecule activator 64 leukemia AML 64 Amrubicin 64 Vaprisol 64 teriflunomide 64 molecularly targeted 64 r hGH 64 galiximab 64 ketolide antibiotic 64 alefacept 64 elvitegravir 64 Interferon gamma 64 MAb 64 vemurafenib 64 sphingosine 1 64 HCV NS5B polymerase 64 protein tyrosine phosphatase 64 Pralatrexate 64 Atrasentan 64 PI3K/Akt pathway inhibitor 64 Phase #b/#a clinical 64 samarium Sm 64 Interferons 64 dihydrochloride 64 D aspartate NMDA receptor 64 accumulate preferentially 64 Xencor XmAb 64 anti CD# antibody 64 developing Bicifadine serotonin 64 Debio 64 vascular disrupting agent 64 IL 1ß 64 adrenergic regulation 64 cetuximab Erbitux ® 64 anticancer therapy 64 INCB# [001] 64 tenofovir Viread 64 sitaxsentan 64 trastuzumab DM1 T DM1 64 TELCYTA 64 factor Xa 64 immune modulator 64 lomitapide 64 Campath ® 64 IMC A# 64 Leukine ® 64 selectively inhibit 64 cleavable linker 64 nitric oxide donating 64 ATTR 64 2 methoxyestradiol 64 vascular disrupting agents 64 TRO# 64 Serostim R 64 serine threonine 64 Valsartan 64 angioedema indications 64 Protexia ® 64 Acute Radiation Syndrome ARS 64 IV Busulfex 64 adecatumumab 64 AMPK activators 64 RECOTHROM ® 64 long acting muscarinic 64 Intravenous Human 64 Talabostat 64 Gefitinib 64 Solazed TM 64 benzimidazole 64 antineoplastic 64 K ras mutations 64 ELND# 64 potent anticancer 64 luteinizing hormone releasing 64 miconazole Lauriad R 64 prostanoid 64 Ramoplanin 64 BLP# Liposome Vaccine 64 SAR# [004] 64 Uricase PEG 64 decitabine 64 refractory gout 64 Olmesartan 64 somatostatin 64 Lixivaptan 64 ESBA# 64 Epirubicin 64 Ataluren 64 GA GCB 64 R baclofen 64 DEB# 64 imatinib mesylate 64 oritavancin 64 antiproliferative effects 64 Fodosine 64 Wafer polifeprosan 64 Phase 1b clinical trials 64 aripiprazole Abilify 64 RNAi therapeutic targeting 64 antiproliferative activity 64 plasmid encoding 64 Thiovir 64 OMP #M# 64 Enzyme Replacement Therapy 64 ALN PCS 64 obatoclax 64 severe gastroparesis 64 zileuton 64 IL #p# 64 Cintredekin Besudotox 64 Ibritumomab Tiuxetan 64 inhibit EGFR 64 LHRH agonist 64 P#X# 64 NeuroSTAT ® 64 CCR1 64 Voreloxin 64 Radiation Therapy SIRT 64 phosphorylates 64 Romiplostim 64 ASONEP 64 SinuNase TM 64 vWF 64 potent topoisomerase II 64 cytokine receptor 64 virus AAV 64 delta isoform 64 vesicular monoamine transporter 64 HuCAL GOLD R 64 relapsed refractory multiple myeloma 64 vaginally administered lidocaine 64 TGF beta1 64 aurora kinase 64 intratumoral injection 64 IRX 2 64 Abiraterone acetate 64 Bosutinib 64 leukemia CLL 64 AA amyloidosis 64 TPI ASM8 64 TNF α 64 Aurexis 64 interleukin IL 64 soluble receptor 64 GVAX ® 64 Zalypsis 64 methylnaltrexone 64 dihydrochloride Tablets 64 CIMZIA TM 64 CYP#A# CYP#D# 64 Bafetinib 64 immunotoxin 64 Anti VEGF 64 antiangiogenic 64 EGF receptor 64 pDC 64 tramiprosate Alzhemed TM 64 oncolytic virus therapy 64 novel synthetic peptide 64 telomerase therapeutic 64 selective antagonists 64 Dacogen decitabine 64 SARMs 64 delta opioid receptor 64 Phase 2b Clinical Trial 64 Phase Ib clinical 64 HGS ETR1 64 RAS MAPK pathway 64 Imatinib mesylate 64 Teplizumab 64 romidepsin 64 ospemifene 64 subcutaneously administered 64 antisense drug 64 Cloretazine VNP#M 64 HMG CoA reductase inhibitor 64 AzaSite Xtra 64 investigational pharmacologically unique 64 Oncolytic 64 N methyl 64 indinavir Crixivan 64 Tyrosine Kinase Inhibitor 64 THR beta agonist 64 Clusterin 64 TTR gene 64 alfa interferon 64 OncoVEX GM CSF 64 cynomolgus monkeys 64 Cloretazine R 64 Selective Inhibitor 64 IFN alpha 64 TGF alpha 64 plasma kallikrein 64 Janus kinase 64 Insegia 64 Kuvan sapropterin dihydrochloride 64 REMOXY R 64 paclitaxel poliglumex 64 Catena ® 64 GRNCM1 64 Polymer Microspheres 64 ErbB1 64 Viprovex TM 64 HER1 64 Tamibarotene 64 PEG Interferon lambda 64 PSMA antibody 64 potent CYP#A# inhibitors 64 microtubule inhibitor 63 tigecycline 63 otelixizumab 63 ELADUR ™ 63 BiTE 63 Aurexis R 63 Curaxin 63 Y2 receptor 63 V#F mutation 63 AEGR 63 Cetrorelix 63 Belerofon 63 CTAP# Capsules 63 anticancer therapeutics 63 injectable formulation 63 thrombopoietin 63 Civacir 63 Phase 2b Trial 63 Melphalan 63 HER pathway 63 small molecule activators 63 siRNA therapeutic 63 HDAC inhibition 63 Perifosine 63 Clolar ® 63 HMG CoA reductase inhibitors 63 synthetic siRNA 63 intranasal formulation 63 PARP inhibitor 63 Phase Ib study 63 chemotherapy induced neutropenia 63 talabostat 63 Ceftaroline 63 TRANSDUR ® 63 selectively inhibits 63 Hedgehog Pathway Inhibitor 63 Protexia R 63 receptor agonist 63 vaccine GRNVAC1 63 Monoclonal 63 Faropenem 63 inhibits protein synthesis 63 gastro intestinal inflammation 63 small molecule tyrosine 63 ibritumomab tiuxetan 63 systemically administered 63 Pirfenidone 63 peptibody 63 ACZ# 63 Thrombin 63 GSK3B 63 Bevirimat 63 rNAPc2 63 OMP #R# 63 HuMax TAC 63 Locked Nucleic Acid 63 Tarvacin 63 peptidic compound 63 rHuPH# recombinant human 63 ISTODAX 63 PrevOnco 63 Budesonide MMX 63 Vidaza R 63 Angiocept 63 Interferon alpha 63 apoptotic pathway 63 Pegylated 63 formerly LymphoStat B 63 TNF receptors 63 Hexvix ® 63 NP2 Enkephalin 63 receptor blocker 63 PEGylated anti 63 Olaparib 63 Cardiomyocytes 63 activin 63 AtuRNAi 63 exon skipping 63 tyrosine kinase inhibitor TKI 63 ZEVALIN ® 63 microtubule targeting 63 Cytotoxic 63 Mucosal 63 BCR ABL 63 therapeutic monoclonal antibodies 63 small molecule glucokinase 63 herpetic keratitis 63 ADAMTS# 63 immunotherapeutic 63 selective agonist 63 etanercept Enbrel 63 Initiates Clinical 63 Eraxis 63 bleomycin 63 Fresenius Biotech 63 antitumor 63 immunotoxins 63 CD# expressing 63 effector functions 63 lintuzumab SGN 63 non alcoholic steatohepatitis 63 selective serotonin 2C receptor 63 c Raf kinase 63 Tarmogen 63 ribonuclease 63 TNFalpha 63 Disease IBD 63 regorafenib 63 anti fibrotic 63 gastrointestinal stromal tumors GIST 63 bendamustine 63 BrachySil 63 NEUGENE 63 Solazed ™ 63 Syk kinase 63 Janus Kinase 63 Cyclosporine 63 Decitabine 63 LHRH antagonist 63 uricase 63 p# inhibitor 63 Everolimus 63 Ep CAM 63 non nucleoside HCV 63 Aviptadil 63 Signaling Pathway 63 Ecallantide 63 cell lymphoma CTCL 63 insulin sensitizer 63 XYOTAX TM 63 Smac mimetics 63 immunotherapeutic agent 63 MOG #-# 63 plus DOXIL 63 acadesine 63 ADI PEG 63 Interferon beta 63 GRASPA ® 63 ocular formulation 63 tafamidis 63 PTH analogue 63 cyclin dependent kinase 63 systemic antifungal 63 Nilotinib 63 Arno Therapeutics 63 monoclonal anti 63 product Fentanyl TAIFUN 63 Cytotoxic T 63 Phase III Clinical Trials 63 IFN α 63 cyclin dependent kinase inhibitor 63 PECAM 63 CTLA 4 63 EZN 63 mycophenolate mofetil 63 TLR9 agonists 63 Oritavancin 63 FasL 63 TBC# 63 acute humoral rejection 63 GRNOPC1 contains 63 HDAC Inhibitor